RxDoctor Payments Data

Hayley Teague, PA

Physician Assistant · Chevy Chase, MDNPI 1326521295

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,909 and has fallen 52.6% since, to $1,377 in 2025. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,643in general payments, 2019–2025

Across 403 payments — averaging $26.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Regeneron Healthcare Solutions, Inc.$814
  • Pfizer$744
  • Sun Pharmaceutical Industries Inc.$718
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$714
  • Lilly USA, LLC$679
  • plus $6K from 23 others

What the payments were for

  • Travel & lodging$30%
  • Food & beverage$10,45498%
  • Education$1862%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,643 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$71,594
Medicare patients
269
Services billed
1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$51,845
Clobetasol Propionate22$1,431
Tacrolimus12$910
Clindamycin Phosphate25$713
Ketoconazole37$487
Triamcinolone Acetonide47$436
Fluocinonide12$320
Mupirocin21$140
Hydrocortisone14$50

Paid to pharmacies, not to this prescriber.

Other physician assistant in Chevy Chase

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →